JCIJohnson Controls
Johnson Controls International plc, headquartered in Cork, Ireland, is a global leader in smart, healthy and sustainable buildings, serving a wide range of customers around the globe. 10-K, Item 1
- Employees
- 87,000
- Headquarters
- Cork, L2
- Next results
- around Feb 3, 2027
Dilution: new shares, stock pay and buybacks
prospectuses (S-3, 424B) of the last three years and the 10-K cash flow From EDGARShares offered
Since Nov 11, 2023: 1 shelf registration; also 3 notes offerings.
- Feb 5, 2026 Shelf registration: shares and other securities, amount not fixed S-3ASR
Every offering filing →“may offer from time to time: • senior or subordinated debt securities; ordinary shares; preferred shares; depositary shares; contracts for the purchase or sale of its debt securities or equity securities or securities of third parties, including any of its affiliates, a basket of such securities, an index or indices of such securities or any combination of the above; warrants for debt securities or equity …”
S-3ASR, Feb 5, 2026 ↗
Diluted shares: 654.10M in the year to Sep 30, 2025 2025 -3.2%2024 -1.7%2023 -1.7%2022 -3.0%
Change in the diluted weighted average share count from the fiscal year before, stock splits taken out. Bars use one scale for stock pay and buybacks. Prospectuses are read from their cover page; preliminary ones are left out. Cash & buybacks, year by year → · How
FY2025, from the cash flow statement in the 10-K, added up.
Came from
| Operating cash flow | $2.6B |
| Debt raised | $1.8B |
| Cash on hand used | $369.0M |
| Other, net investments bought and sold, other financing and investing lines, and exchange rates |
$4.4B |
Went to
| Capital spending | $434.0M |
| Acquisitions | $10.0M |
| Buybacks | $6.0B |
| Dividends | $976.0M |
| Debt repaid | $1.6B |
Each number is a line of the cash flow statement as the company tagged it. "Other, net" is what those lines do not cover (investments bought and sold, other financing and investing lines, and exchange rates); Tickdelta does not estimate it.
Each CEO's years
The CEO of each fiscal year as named in the proxy's pay versus performance table, and what the 10-Ks show for those years. Facts, not a grade.
Mr. Weidemanis
- Operating cash flow
- $2.6B
- Capital spending
- $434.0M
- Acquisitions
- $10.0M
- Buybacks
- $6.0B
- Dividends
- $976.0M
- Stock-based pay
- $140.0M
- Diluted shares since FY2024
- -3.2%
- Revenue since FY2024
- +3%
- Debt since FY2024
- +$397.0M
- CEO pay (reported)
- $36.2M
| Fiscal year to | Buybacks | Dividends | Stock pay | Shares issued for cash | Diluted shares |
|---|---|---|---|---|---|
| 2025-09-30 | $6.0B | $976.0M | $140.0M | - | 654.10M |
| 2024-09-30 | $1.2B | $1.0B | $107.0M | - | 676.00M |
| 2023-09-30 | $625.0M | $980.0M | $107.0M | $42.0M | 687.40M |
| 2022-09-30 | $1.4B | $916.0M | $98.0M | $17.0M | 699.60M |
| 2021-09-30 | $1.3B | $762.0M | $76.0M | $178.0M | 721.10M |
From the XBRL of the 10-Ks (cash flow statement and diluted weighted average shares); each year as reported in the latest 10-K that includes it. Concepts: buybacks = PaymentsForRepurchaseOfCommonStock; dividends = PaymentsOfDividendsCommonStock; sbc = ShareBasedCompensation; diluted_shares = WeightedAverageNumberOfDilutedSharesOutstanding.
Price paid per share
What JCI paid on average for each share it bought back, each fiscal year: dollars spent divided by shares bought, both from the 10-K.
| Fiscal year to | Shares bought | Spent | Average price | |
|---|---|---|---|---|
| 2011-09-30 | 30.00M | $1.3B | $43.33 |
Shares and dollars from the statement of shareholders' equity (the cash flow line also counts shares withheld for taxes, so it is not used). Share counts filed before a stock split are put on today's count. A year where the 10-K does not tag both numbers is left out. The latest year with both numbers tagged is 2011.
Work on JCI in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/JCI/export.csv") into a cell.